Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Alpelisib plus endocrine therapy in patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Analysis of all 3 cohorts of the BYLieve study
- Authors
- Chia, S[Chia, Stephen]; Neven, P[Neven, Patrick]; Ciruelos, EM[Ciruelos, Eva M.]; Lerebours, F[Lerebours, Florence]; Ruiz-Borrego, M[Ruiz-Borrego, Manuel]; Drullinsky, P[Drullinsky, Pamela]; Prat, A[Prat, Aleix]; Park, YH[Park, Yeon Hee]; Juric, D[Juric, Dejan]; Turner, NC[Turner, Nicholas C.]; Chattar, Y[Chattar, Yogesh]; Patino, H[Patino, Heather]; Akdere, M[Akdere, Murat]; Rugo, HS[Rugo, Hope S.]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.